Table 4 |
|||||
|
Cost-effectiveness of mammography screening strategies in Catalonia (Spain) |
|||||
|
Scenario |
Cost |
ΔCost |
Effect |
ΔEffect |
ΔC/ΔE (ICER) |
|
|
|||||
|
(×106 €) |
(×106 €) |
LE |
ΔLE |
€/LE |
|
|
|
|||||
|
Bg |
127.3 |
0 |
|||
|
B 50-69 |
143.4 |
16.2 |
567 |
567 |
28,465 |
|
B 50-70 |
144.6 |
1.1 |
590 |
23 |
49,184 |
|
B 50-74 |
147.0 |
2.5 |
640 |
50 |
50,188 |
|
A 50-74 |
167.0 |
20.0 |
757 |
117 |
170,304 |
|
A 45-74 |
182.1 |
15.1 |
803 |
46 |
330,098 |
|
A 40-74 |
201.5 |
19.4 |
837 |
34 |
573,062 |
|
A 40-79 |
210.4 |
8.9 |
849 |
12 |
715,941 |
|
|
|||||
|
YL |
ΔYL |
€/YL |
|||
|
|
|||||
|
Bg |
127.3 |
0 |
|||
|
B 50-69 |
143.4 |
16.2 |
4,691 |
4,691 |
3,444 |
|
B 45-69 |
151.5 |
8.1 |
5,842 |
1,151 |
7,015 |
|
A 45-69 |
176.0 |
24.4 |
7,917 |
2,075 |
11,777 |
|
A 40-69 |
195.4 |
19.4 |
9,117 |
1,200 |
16,166 |
|
A 40-74 |
201.5 |
6.2 |
9,370 |
253 |
24,415 |
|
A 40-79 |
210.4 |
8.9 |
9,390 |
20 |
451,370 |
|
|
|||||
|
QALY |
ΔQALY |
€/QALY |
|||
|
|
|||||
|
Bg |
127.3 |
0 |
|||
|
B 50-69 |
143.4 |
16.2 |
3,614 |
3,614 |
4,469 |
|
B 45-69 |
151.5 |
8.1 |
4,447 |
833 |
9,694 |
|
B 45-74 |
153.9 |
2.4 |
4,633 |
186 |
12,633 |
|
A 45-69 |
176.0 |
22.1 |
5,979 |
1,346 |
16,411 |
|
A 40-69 |
195.4 |
19.4 |
6,756 |
777 |
24,975 |
|
A 40-74 |
201.5 |
6.2 |
6,987 |
231 |
26,720 |
|
|
|||||
|
Incremental cost per effect (LE, YL and QALY) assuming a cohort of 100,000 women at birth. Dominated or extended-dominated strategies are not included. |
|||||
|
Carles et al. BMC Cancer 2011 11:192 doi:10.1186/1471-2407-11-192 |
|||||
